Vulnerabilities with DICOM in MedTech

DICOM is the format and transport layer that keeps medical imaging moving between modalities, viewers, PACS, and clinical systems. That makes it operationally indispensable-and a frequent source of security exposure when manufacturers and providers treat interoperability as separate from cybersecurity.

DICOM itself is not the problem. Weak implementations, insecure configurations, outdated software, and flat hospital networks are.

Key Takeaways

• DICOM vulnerabilities stem from weak authentication and software flaws.
• Complex integrations increase the attack surface for imaging systems.
• Risks include patient data exposure and compromised image integrity.
• Operational disruptions and financial losses are significant consequences.
• Secure implementation and FDA alignment are critical for mitigation.
• Basic security hygiene prevents most DICOM-related issues.

Table of Contents

• Key Takeaways
• Understanding DICOM in MedTech
• Where DICOM Vulnerabilities Show Up
• The Impact of DICOM Vulnerabilities on MedTech
• Mitigating DICOM Vulnerabilities in MedTech
• The State of DICOM Security in MedTech

Why this matters

DICOM vulnerabilities are not merely theoretical concerns; they represent tangible threats to patient safety, data privacy, and operational continuity within healthcare. Unauthorized access to DICOM data can expose sensitive patient health information (PHI), leading to severe privacy breaches and non-compliance with regulations such as HIPAA. Beyond privacy, compromised DICOM images can be altered, potentially leading to misdiagnoses, delayed treatments, or even adverse patient outcomes. The integrity of medical imaging is paramount for effective clinical decision-making. The FDA's Cybersecurity in Medical Devices Final Guidance, dated February 3, 2026, explicitly mandates that manufacturers address cybersecurity risks throughout the total product lifecycle, including those associated with communication protocols like DICOM. Failure to adequately secure DICOM implementations can result in regulatory actions, significant financial penalties, and reputational damage. Adherence to standards such as IEC 80001-1, ISO 27001, and AAMI TIR57 is crucial for establishing a resilient security posture. These vulnerabilities underscore the critical need for proactive security measures to safeguard both patient well-being and organizational stability.

Understanding DICOM in MedTech

DICOM is the common language for sharing and exchanging medical imaging data. It allows devices and software from different vendors to create, store, transmit, and display images in a consistent way. Without it, cross-system imaging workflows would break down fast.

A DICOM object is more than an image file. It also carries metadata: patient identifiers, study details, modality settings, timestamps, measurements, annotations, and other clinical context. That metadata is exactly why DICOM is so useful-and exactly why it creates privacy and security risk when it is mishandled.

DICOM standards support traditional modalities such as X-ray, CT, MRI, and ultrasound, along with newer workflows including 3D rendering, digital pathology, and advanced visualization. The standard’s reach across so many systems means a DICOM weakness rarely stays contained to one device.

DICOM compliance is not limited to image storage and transmission. It also affects how systems authenticate peers, protect data, log activity, and preserve integrity across clinical workflows. For device manufacturers, that matters not just for security engineering but for FDA submissions, risk management files, and postmarket response.

Where DICOM Vulnerabilities Show Up

Weak authentication and access control

Many DICOM environments still rely on trust assumptions that do not hold up in modern healthcare networks. Systems may accept connections based on IP address, Application Entity Title, or network location without strong identity verification. That is not enough.

When authentication is weak, attackers or unauthorized insiders may gain access to imaging studies, move laterally across connected systems, or push malicious data into clinical workflows. In practice, that can expose protected health information and undermine confidence in image integrity.

Software flaws in viewers, servers, and gateways

The bigger issue is usually not the DICOM standard on paper. It is the code that implements it. DICOM viewers, archives, modality worklist services, converters, and interface engines can all contain memory corruption bugs, parsing errors, insecure deserialization paths, or poor input validation.

An attacker who can exploit those flaws may be able to execute arbitrary code, crash systems, alter image presentation, or tamper with associated metadata. That is not just an IT outage. In the wrong context, it can affect diagnosis, treatment planning, or surgical workflows.

Complex integrations increase the attack surface

DICOM rarely operates alone. It connects to Picture Archiving and Communication Systems (PACS), vendor-neutral archives, radiology viewers, modality worklists, and often EHR platforms. Every interface is another dependency. Every dependency is another place for bad assumptions to hide.

That is why checklist security fails here. A device can claim DICOM support, use encryption somewhere in the workflow, and still be insecure because of poor certificate handling, weak segmentation, default accounts, unsupported legacy services, or unpatched third-party components.

The Impact of DICOM Vulnerabilities on MedTech

The most obvious risk is exposure of patient data. DICOM files can include names, dates of birth, medical record numbers, accession numbers, physician details, and embedded annotations. Unauthorized access can trigger privacy violations, breach notification requirements, and loss of patient trust.

But confidentiality is only part of the problem. Integrity matters just as much. If an attacker modifies an image, changes metadata, swaps studies, or interferes with transmission, clinicians may make decisions based on inaccurate information. That risk deserves more attention than it usually gets.

Healthcare providers also face operational fallout. A successful attack against imaging infrastructure can delay reads, interrupt scheduling, block image retrieval, and force downtime procedures. That affects revenue, patient throughput, and safety at the same time.

For manufacturers, the consequences extend into regulatory and contractual territory. Security weaknesses tied to device software, interfaces, or maintenance practices can create problems during customer security reviews, procurement, incident response, and interactions with the FDA. If a product handles DICOM traffic but cannot support reasonable security controls, the market will notice.

See also: Embedded Cybersecurity Challenges in Medical Devices, IVD Medical Device Cybersecurity Concerns, and MedTech Augmented Reality Cybersecurity.

Exploiting DICOM vulnerabilities can lead to significant financial losses as well. Investigations, forensics, remediation, field updates, legal review, and customer communications are expensive. The cost climbs further when the issue touches shipped devices that cannot be patched easily or safely.

Mitigating DICOM Vulnerabilities in MedTech

Secure the implementation, not just the protocol

The first step is simple: stop assuming DICOM interoperability equals secure design. It does not.

Manufacturers should require strong authentication where feasible, encrypt data in transit, validate inputs aggressively, harden parsing logic, remove unnecessary services, and maintain a software bill of materials that includes DICOM libraries and supporting components. Patch discipline matters. So does secure configuration at deployment.

Network architecture matters too. Imaging systems should not sit exposed on flat internal networks with broad trust relationships. Segmentation, monitored interfaces, least-privilege access, and controlled remote support reduce the blast radius when something goes wrong.

Build for FDA scrutiny and postmarket reality

Security claims around DICOM should be backed by evidence. That means threat modeling, abuse-case analysis, verification of security controls, and testing that reflects realistic hospital environments rather than ideal lab conditions.

For medical device manufacturers, this lines up with what the FDA expects: secure product development, risk-based design controls, documented cybersecurity requirements, and a plan for vulnerability handling after release. If your DICOM workflow depends on assumptions customers cannot enforce, that is a product problem-not something to hand-wave into the user manual.

Be careful with “future” fixes

New ideas get a lot of attention here, especially blockchain and AI-based monitoring. They may have narrow use cases, but they are not substitutes for secure coding, segmentation, patching, logging, and incident response. Most DICOM security failures are still basic engineering failures.

If you want better protection, start with fundamentals: authenticated connections, encrypted transport, hardening, visibility, tested update mechanisms, and a coordinated vulnerability disclosure process.

The State of DICOM Security in MedTech

DICOM remains essential to modern care delivery. That will not change. What needs to change is the habit of treating imaging workflows as special-purpose clinical infrastructure that sits outside normal cybersecurity expectations.

The real risks are clear: weak authentication, exploitable software, exposed metadata, fragile integrations, and poor operational controls. Left alone, those weaknesses can compromise privacy, disrupt care, and create serious regulatory and business consequences.

Manufacturers that take DICOM security seriously will stand out. They design for hostile environments, validate their assumptions, support secure deployment, and prepare for postmarket vulnerability response before customers force the issue.

Blue Goat Cyber helps medical device companies do exactly that. We support device manufacturers with medical device cybersecurity, penetration testing, threat modeling, and alignment with HIPAA and the FDA’s cybersecurity expectations. If DICOM is part of your product or ecosystem, contact us today for cybersecurity help.

Check out our medical device cybersecurity FDA compliance package.

How Blue Goat approaches this

Blue Goat Cyber helps medical device manufacturers identify and mitigate DICOM-related vulnerabilities. Our methodology begins with threat modeling, specifically analyzing how DICOM implementations introduce risk within varied clinical workflows. We then conduct targeted penetration testing of devices and integrated systems to uncover weaknesses in authentication, access control, and data handling within the DICOM standard. Our team, comprised of CISSP and OSCP certified professionals, including ex-military red team members, focuses on actionable remediation strategies. We provide detailed reports and work with your engineering teams to improve the security posture of your DICOM-enabled devices. Our services extend to premarket submissions, ensuring your cybersecurity documentation aligns with FDA expectations. If the FDA raises cybersecurity deficiencies after our submission, we resolve them at no additional cost. Learn more about our specialized support for FDA premarket submissions at https://bluegoatcyber.com/services/fda-premarket-cybersecurity-services.

FAQ

What are common DICOM vulnerabilities?

Common DICOM vulnerabilities include weak authentication mechanisms, software defects in imaging viewers and servers, and insecure configurations arising from complex system integrations. These issues can allow unauthorized access or data manipulation.

How does DICOM metadata create security risks?

DICOM objects contain extensive metadata, such as patient identifiers, study details, and clinical context. If mishandled or inadequately protected, this metadata can lead to privacy breaches, unauthorized disclosure of protected health information, and regulatory non-compliance.

Does the FDA address DICOM cybersecurity in its guidance?

The FDA's February 3, 2026 final guidance on premarket cybersecurity expects medical device manufacturers to address cybersecurity risks across all device functions, including those involving DICOM. This includes secure design, risk management, and postmarket vulnerability handling.

How can manufacturers mitigate DICOM vulnerabilities?

Manufacturers should implement strong authentication, encrypt data in transit, validate inputs, harden parsing logic, and maintain a software bill of materials. Network segmentation and adherence to the FDA's secure product development principles are also essential.

Can exploiting DICOM flaws impact patient safety?

Yes, if an attacker modifies an image, alters metadata, or interferes with transmission, clinicians may make medical decisions based on inaccurate information. This can directly affect diagnosis, treatment planning, and surgical workflows, jeopardizing patient safety.

Related: What is a Coordinated Vulnerability Disclosure Process?

About the author

Christian Espinosa, CISSP, Founder, Blue Goat Cyber. Christian leads a team focused exclusively on medical device cybersecurity for FDA premarket submissions and postmarket compliance. Read more about Christian.